Cargando…
Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level
OBJECTIVE: This study was undertaken to evaluate a multicomponent health system intervention designed to reduce escalating disease‐modifying treatment (DMT) expenditures and improve multiple sclerosis (MS) outcomes by increasing use of preferred formulary and highly effective DMTs (HETs). METHODS: W...
Autores principales: | Langer‐Gould, Annette, Cheng, Stephen C., Li, Bonnie H., Smith, Jessica B., Kanter, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543872/ https://www.ncbi.nlm.nih.gov/pubmed/35285095 http://dx.doi.org/10.1002/ana.26352 |
Ejemplares similares
-
The Multiple Sclerosis Treatment Optimization Program
por: Langer‐Gould, Annette, et al.
Publicado: (2021) -
Multiple sclerosis, rituximab, and COVID‐19
por: Langer‐Gould, Annette, et al.
Publicado: (2021) -
Multiple Sclerosis, Disease-Modifying Therapies, and Infections
por: Langer-Gould, Annette M., et al.
Publicado: (2023) -
Racial and Ethnic Disparities in Multiple Sclerosis Prevalence
por: Langer-Gould, Annette M., et al.
Publicado: (2022) -
Improving quality, affordability, and equity of multiple sclerosis care
por: Langer‐Gould, Annette, et al.
Publicado: (2021)